# Audit of the Effect of Changing From IV to SC Administration of ESA's in Haemodialysis Patients

> **NCT00382044** · — · COMPLETED · sponsor: **Sir Charles Gairdner Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Kidney Failure, Chronic
- Anemia

## Interventions

- **DRUG:** Eprex; Neorecormon; Aranesp

## Key facts

- **NCT ID:** NCT00382044
- **Lead sponsor:** Sir Charles Gairdner Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2007-12
- **Final completion:** 2008-04
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2008-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00382044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00382044, "Audit of the Effect of Changing From IV to SC Administration of ESA's in Haemodialysis Patients". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00382044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*